Respiratory syncytial virus vaccine
id:
respiratory-syncytial-virus-vaccine-178-6629825
title:
Respiratory syncytial virus vaccine
text:
A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year. The RSV vaccines Arexvy (GSK), Abrysvo (Pfizer), and Mresvia (Moderna) are approved for medical use in the United States. Arexvy is approved for medical use in the United States, in the European Union, and in Canada for adults aged 60 years of age and older. Arexvy is approved in the US for
brand slug:
wiki
category slug:
encyclopedia
description:
Vaccine against respiratory syncytial virus
original url:
https://en.wikipedia.org/wiki/Respiratory_syncytial_virus_vaccine
date created:
2020-02-25T12:24:45Z
date modified:
2024-09-04T12:51:55Z
main entity:
{"identifier":"Q96401585","url":"https://www.wikidata.org/entity/Q96401585"}
image:
fields total:
13
integrity:
15